Gayretli Aydin 2015.

Methods	Retrospective cohort study
Participants	26 confirmed cases Age 10 years ± 2, sex 30.7% female
Interventions	Ribavirin 30 mg/kg as an initial loading dose, followed by 15 mg/kg every 6 h for 4 days, and then 7.5 mg/kg every 8 h for 6 days; oral
Outcomes	Mortality
Location and dates	Maternity and Children’s Research and Education Hospital, Ankara, Turkey, tertiary hospital 2005 ‐ 2013
Number of days since onset of symptoms (mean/SD)	NR
Supportive therapy	Replacement of fluid and electrolytes, and administration of platelet suspension, FFP and erythrocyte suspension
Notes	Study only included children